ODAIA Introduces MAPTUAL Sphere to Help Pharma Commercial Teams to Improve Engagement with Healthcare Professionals

• The new offering complements ODAIA’s MAPTUAL Field to equip pharma commercial teams with AI-powered insights that better segment HCP audience reach
• Enables teams to visualize ROI of each channel and campaign to enhance pharma-physician engagement
• Provides valuable predictive insights and forecasts across all brands in a given therapeutic area

Today, ODAIA, the company empowering pharma’s next generation of engagement with healthcare professionals, announces MAPTUAL Sphere. The product helps drive deeper, stronger connections between providers and life sciences organizations to better serve healthcare providers (HCPs) and optimize relevant treatment opportunities for patients.

The pandemic reduced pharma’s access to healthcare providers. Yet, the importance of reaching physicians to educate about new therapeutic options for their patients has not diminished. As 65% of physicians indicate that they’ve been “spammed” with digital content from a pharma company, the reliance on analytical solutions delivering insights from outdated data is a massive barrier to bringing relevant and real-time information to HCPs.

“Pharma teams are often constrained by the dated and inefficient tools they have available to reach physicians in need of their product, and ultimately patients,” said Philip Poulidis, ODAIA CEO and co-founder. “MAPTUAL uses advanced AI technology to enable commercial teams to dynamically target and segment physicians based on their propensity to treat target patients while also tracking the precise value of each engagement. It ensures the right healthcare providers are getting timely information about the therapies they need in order to treat their patients.”

MAPTUAL Sphere follows ODAIA’s flagship MAPTUAL Field product, which puts HCP real-time targeting, segmentation and predictive insights directly into the hands of pharma sales reps who are educating providers on new therapies and standards of care. Like MAPTUAL Field, MAPTUAL Sphere is powered by the MAPTUAL platform, which analyzes prescriber transactions, anonymized patient health claims data, population demographic and socioeconomic data, anonymized lab data, and more.

MAPTUAL Sphere extends ODAIA’s predictive analytics SaaS platform to pharma commercial and brand management teams to provide a bird’s eye view at the national, regional, or territory level and support segmentation, targeting, and territory planning. MAPTUAL Sphere is at the forefront of connecting pharma commercial teams to optimal healthcare providers with benefits including:

• Improved operational efficiencies for segmentation, targeting, forecasting, territory planning and alignment
• Omni-channel Attribution for real-time analysis of sales and marketing activities by HCP, region, segment, etc. to discover the impact of channel activity as it correlates to Rx lift

Key features of MAPTUAL Sphere include:

• Predictive Analytics and Forecasting: Proactively business plan with predictive insights across all brands in a given therapeutic area.
• Dynamic and Predictive Segmentation: Get a more holistic view of HCP trends and responses to campaigns and sales efforts by tracking and visualizing HCPs journeys through a collection of predefined segments. Never work off of outdated, static insights or target lists again.

This announcement comes on the heels of ODAIA’s oversubscribed $13.8M Series A to bring the company’s total funding to $18.4M and the publishing of a case study demonstrating MAPTUAL Field’s ability to drive 8x ROI for a top 10 pharmaceutical company.

To learn more about MAPTUAL Sphere, please visit: https://www.odaia.ai/maptual-sphere-for-head-office-teams

About ODAIA
ODAIA is a pioneer in automated sales and marketing insights. Founded out of the University of Toronto, ODAIA is led by an experienced group of serial entrepreneurs, data scientists and AI engineers and is trusted by leading global organizations. ODAIA’s first product, MAPTUAL Field, leverages its proprietary engine to help prospect, qualify and engage pharma customers. The product has seen strong traction and demonstrated success among the top Fortune 500 biopharma companies. To learn more, visit www.odaia.ai or follow on the company social at @odaiaAI.

Contact Information

Molly O’Connor

Director

VSC on behalf of ODAIA

odaia@vsc.co